baber/WOPTO huggingface dataset:
Patent CA-2652448-A1 (CA)
Title: Contact lens back surface design with back optic zone diameter and axial edge lift vary as a function of back optic zone radius
Inventor: RAJAI PAYMAN
IPC: G02C7/04
Filed: 2008-12-24
Abstract: To design the back surface of contact lenses, it is common to consider a model shape for the cornea then try to design the back surface of contact lens which provides the desired amount of Tear Layer Thickness (TLT) and Edge Clearance (EC) after placing on the cornea. Following the proper theoretical model, we will have a better fit on patient's cornea and more patients' comfort. In this invention, Back Optic Zone Diameter (BOZD) plays an important role in designing back surface of contact lenses. According to the invented design, BOZD and Axial Edge Lift (AEL) vary as a function of Back Optic Zone Radius and the cornea curvature. This design allows the contact lens to have better position on the cornea and provides our desired values of TLT and EC. In addition to TLT and EC controlled design, other features of this method are BOZD controlled design and Sagittal depths controlled design.
Patent CA-2653817-A1 (CA)
Inventor: WHITTED WILLIAM
IPC: H05K7/20
Filed: 2006-06-27
Abstract: A computer system may include a connecting hub having a plurality of docking regions and be configured to provide to each docking region electrical power, a data network interface, a cooling fluid supply and a cooling fluid return; and a plurality of shipping containers that each enclose a modular computing environment that incrementally adds computing power to the system. Each shipping container may include a) a plurality of processing units coupled to the data network interface, each of which include a microprocessor; b) a heat exchanger configured to remove heat generated by the plurality of processing units by circulating cooling fluid from the supply through the heat exchanger and discharging it into the return; and c) docking members configured to releaseably couple to the connecting hub at one of the docking regions to receive electrical power, connect to the data network interface, and receive and discharge cooling fluid.
Patent CA-2658365-A1 (CA)
Inventor: PHILIPPE MICHEL JOSEPH RENE
IPC: E04G11/06
Filed: 2007-07-13
Abstract: An insulated concrete form (ICF) panel reinforcement is disclosed. The ICF comprises a main panel, a reinforcement on the main panel for stiffening the main panel, a spacer retention element integrated in the reinforcement for securing a spacer to the panel, and a first opposing panel opposite the main panel and having a first opposing spacer retention element integrated therein for securing the spacer to the first opposing panel. The ICF panel reinforcement is particularly useful at high stress locations in ICF systems, such as at T-wall intersections.
Patent CA-2658518-A1 (CA)
Inventor: ATTAR MAYSSA
IPC: A61K9/00
Filed: 2007-07-23
Abstract: Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
Patent CA-2660185-A1 (CA)
Title: Compliance assessment reporting service
Inventor: HURRY JOHN
IPC: G06Q30/00
Filed: 2007-08-13
Abstract: Disclosed herein is a method for providing assurance information regarding a business entity to a customer for an electronic transaction. The method comprises submitting a compliance token to a certificate authority as part of a certificate signing request wherein the compliance token comprises an assessment result describing the business entity's level of compliance with an assurance policy, as determined by an assessor, receiving an assurance certificate from the certificate authority, wherein the certificate includes the compliance token, and providing the assurance certificate to a customer in order to provide security information to the customer as part of an electronic transaction.
Patent CA-2663388-A1 (CA)
Inventor: VAN DEN BRINK EDWARD NORBERT
IPC: C12N5/10
Filed: 2007-09-06
Abstract: The present invention relates to binding molecules such as human monoclonal antibodies that bind to influenza virus H5N1 and have neutralizing activity against influenza virus H5N1. The disclosure provides nucleic acid molecules encoding the antibodies, their sequences and compositions comprising the antibodies and methods of identifying or producing the ant ibodies. The antibodies can be used in the diagnosis, prophylaxis and/or treatment of an influenza virus H5N1 infection. In a preferred embodiment, the antibodies provide cross- subt ype protection in vivo, such that infections with H5, H2, H6, H9 and H1-based influenza subtypes can be prevented and/or treated.
Patent CA-2663736-A1 (CA)
Inventor: BROEDERS WARD
IPC: C21D1/00
Filed: 2009-04-22
Abstract: Method for increasing the fatigue strength of a mechanical part of a wind turbine and/or for reducing the tendency to form what are called "white etching cracks" or "brittle flakes" in such a bearing, characterised in that it consists in making one or several of the bearing rings and/or roller elements concerned of the bearing at least partly of a hardened steel having a carbon content between 0,4 and 0,8 percent by weight.
Patent CA-2663817-A1 (CA)
Inventor: KEITH DAVID J
IPC: A61K47/02
Filed: 2007-09-20
Abstract: The use of a borate/polyol and zinc system to enhance the antimicrobial activity of multi-dose pharmaceutical compositions is described. The compositions do not require a conventional anti-microbial preservative and therefore are referred to as being 'self-preserved'. The compositions possess sufficient antimicrobial activity to satisfy the preservative efficacy requirements of the USP for aqueous ophthalmic compositions.
Patent CA-2666104-A1 (CA)
Inventor: NGADI MICHAEL
IPC: A23L19/00
Filed: 2007-09-18
Abstract: The present invention relates to a process of producing a stable and dens ified pellet and the enhancement of phytochemical extraction from plant mate rials using pulsed electric field. The process is applied with a step involv ing pressing, wherein the pressing and the pulse electric field treatment ca n be accomplished in a unique treatment chamber.
Patent CA-2666349-A1 (CA)
Title: Hydroprocessing methods for bulk group viii/group vib metal catalysts
Inventor: ISMAIL NIVEEN S
IPC: C10G47/02
Filed: 2007-10-11
Abstract: Hydrocarbon feedstocks are hydroprocessed in reaction systems including at least one catalyst stage containing bulk metallic catalysts comprised of a Group VIII metal, a Group VIB metal, and an organic compound-based component. The catalysts are prepared by a method wherein precursors of both metals are mixed and interacted with at least one organic acid, such as glyoxylic acid, dried, heated, and sulfided. The catalysts are used for hydroprocessing, particularly hydrodesulfurizaton and hydrodenitrogenation, of hydrocarbon feedstocks.
Patent CA-2669939-A1 (CA)
Inventor: BHATIA SANGEETA N
IPC: G01N33/543
Filed: 2007-10-12
Abstract: The present invention is drawn to the generation of micropatterns of biomolecules and cells on standard laboratory materials through selective ablation of a physisorbed biomolecule with oxygen plasma. In certain embodiments, oxygen plasma is able to ablate selectively physisorbed layers of biomolecules (e.g., type-I collagen, fibronectin, laminin, and Matrigel) along complex non-linear paths which are difficult or impossible to pattern using alternative methods. In addition, certain embodiments of the present invention relate to the micropatterning of multiple cell types on curved surfaces, multiwell plates, and flat bottom flasks. The invention also features kits for use with the subject methods.
Patent CA-2670136-A1 (CA)
Inventor: HAN AMI QI
IPC: C07D489/02
Filed: 2007-11-21
Abstract: Novel 7,8-saturated-4,5-epoxy-morphinanium analogs are disclosed. Pharmaceutical compositions containing the 7,8-saturated-4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opioid receptors.
Patent CA-2678190-A1 (CA)
Title: Nouveaux facteurs viii pour le traitement des hemophiles de type a
Inventor: BLESA STEPHANE
IPC: C07K14/755
Filed: 2008-02-22
Abstract: La présente invention est relative à des variants améliorés du FVIII huma in présentant au moins une substitution dans le domaine A2 et/ou C2. La prés ente invention est également relative à leurs utilisations 5 pour le traitem ent de l'hémophilie de type A, notamment chez des patients à inhibiteurs.
Patent CA-2679939-A1 (CA)
Title: Composition and method for treating papilloma virus and equine sarcoids
Inventor: FERRARI STEFANO
IPC: A61K38/46
Filed: 2008-02-29
Abstract: A composition of lysozyme and a pharmaceutically acceptable carrier is active against the papilloma virus in both humans and animals. The composition can be used to treat women suffering from cervical cancer. The composition can also be used to treat cows and horses suffering sarcoids. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader quickly to ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the appended issued claims. 37 CFR § 1.72(b).
Patent CA-2680398-A1 (CA)
Inventor: CAI XIONG
IPC: A61K31/506
Filed: 2007-09-10
Abstract: The present invention relates to Raf kinase inhibitors containing zinc-binding and their use in the treatment of Raf related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
Patent CA-2682294-A1 (CA)
Title: Plant productivity enhancement by combining chemical agents with transgenic modifications
Inventor: HUDELSON TIMOTHY
IPC: A01N47/02
Filed: 2008-04-23
Abstract: The present invention relates to the enhancement of plant productivity by combining chemical agents with transgenic modifications.
Patent CA-2682768-A1 (CA)
Title: Polycarbonate molding compositions
Inventor: NAWROTH MANFRED
IPC: C08K3/34
Filed: 2008-03-22
Abstract: The invention relates to talcum-reinforced polycarbonate compositions containing A) 10 to 100 parts by weight, preferably 80 to 100 parts by weight, particularly preferably 85 to 100 parts by weight, and particularly also 100 parts by weight, relative to the sum of components A and B, of a polycarbonate, a polyester carbonate, or a mixture thereof; B) 0 to 90 parts by weight, preferably 0 to 20 parts by weight, particularly preferably 0 to 15 parts by weight and particularly also 0 parts by weight, relative to the sum of components A and B, of a polymer selected from at least one of the group comprising grafted polymers prepared by an emulsion polymerization, grafted polymers prepared by mass polymerization, rubber-free vinyl homopolymers, and rubber-free vinyl copolymers; C) 7 to 30% by weight, preferably 7 to 22% by weight, particularly preferably 7 to 15% by weight, and particularly preferably 7 to 12% by weight, relative to the total composition, of talcum, preferably a talcum with an Al2O3 content of < 1.0% by weight, particularly a talcum with an average particle diameter d50 of < 2 mm; D) 0.01 to 1% by weight, preferably 0.01 to 0.5% by weight, particularly preferably 0.02 to 0.4% by weight, relative to the total composition, of a Bronstedt acid; E) 0 to 20% by weight, preferably 0 to 5% by weight, and particularly preferably 0.2 to 4% by weight, of at least one polymer additive, wherein the composition is free of aromatic or partially aromatic polyesters, wherein the sum of the percentages by weight of components A and B in the total composition is calculated from the difference between 100% by weight and the sum of the percentages by weight of components C, D, and E, and wherein the total composition is understood to be the sum of the percentages by weight of all the components A + B + C + D + E = 100% by weight. Compared to the known prior art, the talcum-reinforced polycarbonate compositions have an improved ductility, heat distortion stability, and thermal stability during compounding and processing (molding). Additional subjects of the invention relate to the use of the composition for the production of molded objects and two-component construction elements.
Patent CA-2685140-A1 (CA)
Title: Emballage pour article a fumer en forme de tige et son ebauche
Inventor: TANBO HITOSHI
IPC: B65D85/10
Filed: 2008-04-21
Abstract: L'invention concerne un emballage à couvercle articulé qui comprend un corps de boîte et un couvercle faits d'une feuille d'ébauche (28). L'ébauche (28) a des agencements d'encoche de type bande (16a, 18a) formant les bords verticaux du corps de boîte et du couvercle en bords arrondis. Les agencements d'encoche (16a, 18a) ont un grand nombre de rangées d'encoches (19) formées seulement dans la surface interne de l'ébauche (28). Les rangées d'encoches (19) sont inclinées par rapport à la direction longitudinale de l'ébauche (28) et agencées à des intervalles dans la direction latérale des agencements d'encoche (16a, 18a).
Patent CA-2688123-A1 (CA)
Title: Architecture for health monitoring systems
Inventor: STEFKOVIC GREGORY
IPC: G16H10/60
Filed: 2008-05-29
Abstract: An architecture allows individual system components to be developed and tested individually, i.e., as distinct modules, and to be subsequently combined through standardized electrical and communication interfaces. Any combination of these modules can be implemented to form different products that provide any number of functions, such as an integrated system for monitoring a health condition and/or delivering a medication. The architecture also provides an approach for dynamically updating the product and offering its users the latest generation of technology even after the users have already purchased the product. In particular, the embodiments employ the communication interfaces to also provide connection to a remote network that can update or upgrade the product's software when the product is out in the field.
Patent CA-2688144-A1 (CA)
Title: Retention means for a venous access port assembly
Inventor: BIZUP RAYMOND
IPC: A61M39/02
Filed: 2008-06-20
Abstract: A venous access port assembly (10) having a housing base (28) with a discharge stem (16), a septum (14) and a cap (36). An interior reservoir (22) is defined by a well (30) in the housing base and the bottom surface of the septum, and a passageway (20) extends from the reservoir through the discharge stem (16). The cap (36) is secured to the housing base (28) and securely retains the septum in the assembly (10), compressing an annular flange (44) of the septum against a septum seat (46) of the housing base. Horizontal ribs on the interior of the cap snap into complementary grooves on the side wall of the housing base to mechanically lock together the cap and housing base during curing of the solvent bonding agent. The cap (48) is mechanically secured to the housing base (28) as well as being bonded thereto. Crush ribs (72) on the interior surface (68) of the cap (36), precisely center the cap about the housing base during assembly and compensating for manufacturing tolerances.
Patent CA-2688150-A1 (CA)
Inventor: AVERY ANDREW RICHARD
IPC: A61K8/89
Filed: 2008-06-02
Abstract: The invention provides a hair care composition comprising: (i)emulsified particles of an alkyl modified silicone, and (ii)emulsified particles of a non-volatile, non-alkyl modified silicone. The compositions are particularly suitable for use asa conditioner for the treatmentof hair (typically after shampooing) and subsequent rinsing. Compositions according to the invention deliver effective conditioning to the hair, without unacceptably high deposition.
Patent CA-2689190-A1 (CA)
Title: Vinyl acetate/ vinyl 2-ethylhexanoate co-polymer binder resins
Inventor: MCLENNAN ALISTAIR JOHN
IPC: C08L31/04
Filed: 2009-12-23
Abstract: A polymer composition suitable as a binder resin for fibrous substrates such as woven or nonwoven products including textiles, apparel in general, papers, scrim, engineered fabrics, glass or other mineral fibers, roofing or flooring materials is disclosed. The binder resin comprises a copolymer obtainable by reacting: (i) 5-95 pphwm of vinyl acetate; (ii) 95-5 pphwm of at least one vinyl ester of .alpha.-monosubstituted fatty acids; and (iii) 10-0.1 pphwm of at least one functional monomer, such as self-crosslinking monomer, and optionally other comonomers.
Patent CA-2690579-A1 (CA)
Title: Cold casting method and apparatus
Inventor: BARTHOLOMEW DAVID A
IPC: B22F3/12
Filed: 2010-01-20
Abstract: Method of cold casting a composite product, a pressure curing apparatus for use in curing a composite mixture under pressure, and use of the pressure curing apparatus in the present method. The method of cold casting a composite product includes the step of curing a composite resin mixture under pressure to eliminate the appearance of bubbles in the composite product. The pressure curing apparatus comprises, amongst other things, a pressure chamber that is sized and shaped to conform with the size and shape of a mold inserted therein to minimize wasted space and reduce the amount of energy required to pressurize the chamber.
Patent CA-2690693-A1 (CA)
Inventor: BERGEN AL
IPC: A01D47/00
Filed: 2010-01-21
Abstract: A trailer apparatus for transporting a harvest header has a main beam on wheels.  A bed assembly is pivotally attached to the main beam above the main beam such that when one side of the bed assembly moves up, an opposite side moves down.  The bed assembly is supported at a desired tilt angle by adjustable tilt, The bed assembly includes a movable side extension along one side that is movable through a range from an extended position to a retracted position and can be releasably locked in the range. The tilt angle can be adjusted independently of the position of the side extension. A middle portion of the main beam and bed assembly can be laterally offset to form a recess to accommodate lift arms of a self propelled swather when the swather header is loaded on the bed assembly.
Patent CA-2691522-A1 (CA)
Inventor: PUSKAS LASZLO
IPC: C07D401/12
Filed: 2008-06-20
Abstract: The present invention relates to compounds that are suitable for treatment of disease states and influence cellular vesicular systems, especially the formation and/ or function of lipid droplets, said compound having the general formula I (I) wherein X are each independently hydrogen, halogen, -C1-20-alkyl, -C2-20-alkenyl, -C2-20-alkinyl, -C5-6-cykloalkyl, aryl, aralkyl, adamantyl,-heterocyclic, hydroxyl, hydroxyalkyl, Or -N-(R1, R2) group; n is 0, 1, 2, 3, or 4; R1 and R2 may each be independently hydrogen, straight or branching alkyl, cyclo-alkyl, aryl, aralkyl, heterocyclic group, wherein each is un-substituted or halogen substituted; or R1 and R2 together with the nitrogen in between them form a 5 or 6 member ring; A is a single bond, -O-, -S-, -CH2-, or -NH-; Y is O or S; Z is 0 or S; R' and R" are each independently methyl, ethyl, isopropyl, isobuthyl, sec- butyl or terc-butyl; with the restriction that: X(n) cannot all be fluorine, and A be a single bond, and Y, as well as Z be O, and R', as well as R" be isopropyl, and R1 and R2 be hydrogen at the same time. The present invention further relates to pharmaceutical compositions comprising such compounds and to use of such compounds for treatment of disease states.
Patent CA-2693654-A1 (CA)
Inventor: BRAHMASANDRA SUNDARESH N
IPC: G01N33/544
Filed: 2008-07-11
Abstract: Methods for processing polynucleotide-containing biological samples, and materials for capturing polynucleotide molecules such as RNA and/or DNA from such samples. The RNA and/or DNA is captured by polyamidoamine (PAMAM(Gener-ation 0)) bound to a surface, such as the surface of magnetic particles. The methods and materials have high efficiency of binding RNA and of DNA, and of release, and thereby permit quantitative determinations.
Patent CA-2695647-A1 (CA)
Inventor: CHIANG WEI-LIANG
IPC: E05B55/00
Filed: 2010-03-08
Abstract: A latch-bolt mechanism includes a housing, a latch-bolt, and a distance-adjusting device. The latch-bolt is movable relative to the housing between an extended position and a retracted position. The distance-adjusting device includes a movable unit movable in the housing between first and second vertical positions and including a first drive member that is connected to the latch-bolt for driving movement of the latch-bolt from the extended position to the retracted position when the movable unit is disposed at either the first or second vertical positions, and a fastener unit for locking the movable unit releaseably at a selected one of the first and second vertical positions.
Patent CA-2696301-A1 (CA)
Title: High-embossed card-shaped data carrier
Inventor: SCHILLER CHRISTOPH
IPC: G06K19/077
Filed: 2008-08-13
Abstract: The invention relates to a method for producing a portable card-shaped data carrier (10) with a high embossing (65). It comprises the steps of supplying a planar circuit carrier (30), integrating the circuit carrier (30) in a card-shaped data carrier body (20) of the data carrier (10) and high embossing the data carrier body (20). Therein in at least one surface area (40) of the circuit carrier (30) at least one through opening (52; 54;  56) is produced and the data carrier body (20) is high embossed in an embossing area (60) overlapping with the at least one surface area (40) of the circuit carrier (30). In this fashion an easy high embossing of a corresponding data carrier (10) is rendered possible.
Patent CA-2696968-A1 (CA)
Inventor: SCHONBERGER JAN
IPC: C08J9/30
Filed: 2008-08-08
Abstract: The invention relates to compositions for the production of hydrophilized polyurethane foams, particularly for wound treatment, wherein the composition containing a polyurethane dispersion and special additives is foamed and dried.
Patent CA-2699055-A1 (CA)
Inventor: BEVEC DORIAN
IPC: A61K38/08
Filed: 2008-09-09
Abstract: The present invention is directed to the use of the peptide compound Tyr-Gly-Leu-Phe- OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Tyr-Gly-Leu-Phe-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
Patent CA-2700359-A1 (CA)
Inventor: LARSON LARRY
IPC: B60P1/38
Filed: 2008-10-14
Abstract: This invention relates to a novel seal coat process and equipment for applying the seal coat to improve the reliability of seal coat aggregate retention to the surface of the pavement by increasing the surface area of aggregate covered with binder and interlocking the aggregate with finer gradation material such as choke stone.  It also relates to the use of lower amounts of asphalt binder, lower amounts of aggregate application, lower quality of aggregates, use of softer binders, and faster release to traffic times.
Patent CA-2703750-A1 (CA)
Inventor: STUART MARTIN A
IPC: H01S3/10
Filed: 2008-10-24
Abstract: An innovative device and method for providing a laser system utilizing high efficiency diode lasers and optionally the high quality beam characteristics of a crystal gain medium single mode laser by utilizing an optical and mechanical method of forming the beam and directing it to the desired target.
Patent CA-2703961-A1 (CA)
Inventor: DAVIES MARK C
IPC: C10L10/18
Filed: 2008-10-23
Abstract: Succinimide dispersant produced by reacting a hydrocarbyl-substituted succinic anhydride and an amine having at least one primary amino group and at least one secondary amino group where the succinimide detergents are useful as additives in fuels.